Channing Global Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$506K |
| 2 |
HDFC Bank
HDB
|
+$420K |
| 3 |
ICICI Bank
IBN
|
+$195K |
| 4 |
Sumitomo Mitsui Financial
SMFG
|
+$37.6K |
| 5 |
SAP
SAP
|
+$34.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$2.66M |
| 2 |
Amazon
AMZN
|
+$2.11M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.08M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.91M |
| 5 |
International Flavors & Fragrances
IFF
|
+$1.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.28% |
| 2 | Technology | 24.26% |
| 3 | Communication Services | 11.99% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.43% |
Similar funds
Channing Global Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Channing Global Advisors held 47 positions worth $144M, down 6.8% from $155M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Channing Global Advisors withdrew a net $22.5M in Q3 2025, closing 6 positions and reducing 23 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $1.84M position sold in full.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 36% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Channing Global Advisors added an estimated $506K to Novo Nordisk.
- Channing Global Advisors added most to Novo Nordisk in Q3 2025, an estimated $506K increase.
- Channing Global Advisors's biggest Q3 2025 reduction was UBS Group, cutting an estimated $2.66M.
- Channing Global Advisors fully exited International Flavors & Fragrances in Q3 2025, selling an estimated $1.84M.
- Channing Global Advisors's ten largest holdings make up 72% of its $144M portfolio in Q3 2025.
- Channing Global Advisors opened 0 new positions and closed 6 in Q3 2025.
- Channing Global Advisors's portfolio value fell 6.8% quarter-over-quarter to $144M.
Based on Channing Global Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.